Stocks News

LAST PRICE
353.0000
TODAY'S CHANGE (%)
Trending Up1.6700 (0.4753%)

Bid / Lots
320.0000/ 1
Ask / Lots
356.0000/ 2
Open / Previous Close
349.1100 / 351.3300
Day Range
Low 349.1100
High 354.7000
52 Week Range
Low 208.6249
High 366.0800
Volume
900,847
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Sep 16, 2024
- Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million, from 2:17PM ET on Monday Sep 16, 2024 by MT Newswires
  2:17PM ET on Monday Sep 16, 2024 by MT Newswires
  Companies Mentioned: NVS, UTHR, LQDA
  02:17 PM EDT, 09/16/2024 (MT Newswires) -- Liquidia (LQDA) shares were climbing over 1% Monday after a federal judge sided with the biopharmaceutical company and a partner firm in their legal fight alleging United Therapeutics (UTHR) interfered with...
- DJ Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M, from 10:34AM ET on Monday Sep 16, 2024 by Dow Jones
  10:34AM ET on Monday Sep 16, 2024 by Dow Jones
  Companies Mentioned: UTHR, LQDA
  
  By Don Nico Forbes
  
  Liquidia said a U.S. court determined losses caused by interference from United Therapeutics during the launch of its generic Treprostinil Injection were in excess of $137 million.
Sep 10, 2024
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind--Ever, from 7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
  7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Report available at corporateresponsibility.unither.com
  SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--September 10, 2024--
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2024 Corporate Responsibility and Public Benefit Report (Report) covering its FY 2023 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of patients and other stakeholders.
Sep 4, 2024
- United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing, from 4:57PM ET on Wednesday Sep 04, 2024 by MT Newswires
  4:57PM ET on Wednesday Sep 04, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:57 PM EDT, 09/04/2024 (MT Newswires) -- James Edgemond, CFO and Treasurer, on September 03, 2024, sold 7,785 shares in United Therapeutics (UTHR) for $2,821,050. Following the Form 4 filing with the SEC, Edgemond has control over a total of 3,162...
Aug 28, 2024
- Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug, from 5:42PM ET on Wednesday Aug 28, 2024 by MT Newswires
  5:42PM ET on Wednesday Aug 28, 2024 by MT Newswires
  Companies Mentioned: UTHR, LQDA
  05:42 PM EDT, 08/28/2024 (MT Newswires) -- Liquidia (LQDA) is seeking a preliminary injunction on an Aug. 16 decision by the US Food and Drug Administration to keep its Yutrepia drug off the market until the exclusivity period for a rival medication...

Yesterday
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  Companies Mentioned: NBIX
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  Companies Mentioned: NBIX
Sep 18, 2024
- BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO(R) (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting, from 8:01AM ET on Wednesday Sep 18, 2024 by PR Newswire
  8:01AM ET on Wednesday Sep 18, 2024 by PR Newswire
  Companies Mentioned: BMRN
- BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO(R) (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting, from 8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: BMRN
- JMP Securities Initiates BeiGene at Outperform With $288 Price Target, from 7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires
  7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires
  Companies Mentioned: BGNE
- DJ BeiGene Initiated at Market Outperform by JMP Securities, from 5:52AM ET on Wednesday Sep 18, 2024 by Dow Jones
  5:52AM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: BGNE
Sep 17, 2024
- DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by Scotiabank, from 11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones
  11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Buy by Truist Securities, from 10:49AM ET on Tuesday Sep 17, 2024 by Dow Jones
  10:49AM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo, from 10:20AM ET on Tuesday Sep 17, 2024 by Dow Jones
  10:20AM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by RBC Capital, from 10:11AM ET on Tuesday Sep 17, 2024 by Dow Jones
  10:11AM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: BMRN

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Sep 16, 2024

Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million, from 2:17PM ET on Monday Sep 16, 2024 by MT Newswires

DJ Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M, from 10:34AM ET on Monday Sep 16, 2024 by Dow Jones

Sep 10, 2024

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind--Ever, from 7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones

Sep 4, 2024

United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing, from 4:57PM ET on Wednesday Sep 04, 2024 by MT Newswires

Aug 28, 2024

Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug, from 5:42PM ET on Wednesday Aug 28, 2024 by MT Newswires

Peers Headlines

Yesterday

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones

Sep 18, 2024

JMP Securities Initiates BeiGene at Outperform With $288 Price Target, from 7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires

DJ BeiGene Initiated at Market Outperform by JMP Securities, from 5:52AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 17, 2024

DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by Scotiabank, from 11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Buy by Truist Securities, from 10:49AM ET on Tuesday Sep 17, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo, from 10:20AM ET on Tuesday Sep 17, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by RBC Capital, from 10:11AM ET on Tuesday Sep 17, 2024 by Dow Jones